HALL LAURIE J TRUSTEE - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$738,000
-43.9%
4700.0%0.00%
-100.0%
Q1 2017$1,316,000
+131500.0%
4700.0%0.00%0.0%
Q4 2016$1,0000.0%4700.0%0.00%0.0%
Q2 2016$1,0000.0%470
+113.6%
0.00%0.0%
Q1 2016$1,0002200.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders